๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Morbid obesity, nonalcoholic fatty liver disease, and weight loss surgery

โœ Scribed by Savita Srivastava; Zobair M. Younossi


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
88 KB
Volume
42
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


Objective:

This study examines the impact of biliopancreatic diversion, a malabsorptive variant of gastric bypass, on liver histology.

Methods:

Liver samples were collected from 689 severely obese (bmi 47 +/- 9 kg m(2)) patients undergoing biliopancreatic diversion. exclusion criteria included: history of hepatitis, exposure to hepatotoxic medications, prior weight loss surgery, and alcohol consumption greater than 100 grams per week. one group of 14 patients had cirrhosis in their initial biopsy. eleven of those 14 patients underwent multiple biopsies to monitor their liver disease. a second group of 104 patients had re-operations and a second liver biopsy. a hepatopathologist conducted blind evaluations of all biopsy specimens looking for steatosis and fibrosis.

Results:

All patients lost weight and showed improvement in their metabolic syndrome. of the 104 patients undergoing re-operation with a second liver biopsy, 28 showed a decrease in severe fibrosis, while 42 patients developed mild fibrosis. on average, this group lost 38 +/- 18 kg over 41 +/- 25 post-surgical months. a sub-group analysis revealed an association between increased fibrosis and post-operative low serum albumin, diarrhea, pre-operative alcohol consumption, and menopausal status. the eleven patients with cirrhosis in their initial biopsy showed a reduction in their fibrosis grade (mean fibrosis grade from 5 to 3) during nine years of follow-up care.

Conclusion:

These findings indicate that significant weight loss after biliopancreatic diversion can improve liver histology in patients with advanced fibrosis.


๐Ÿ“œ SIMILAR VOLUMES


Fitness versus fatness: Moving beyond we
โœ Nathan A. Johnson; Jacob George ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 217 KB ๐Ÿ‘ 1 views

The rapid emergence of nonalcoholic fatty liver disease (NAFLD) as a cause of both liver-related morbidity and mortality and cardiometabolic risk has led to the search for effective lifestyle strategies to reduce liver fat. Lifestyle intervention comprising dietary restriction in conjunction with in

Reduced cardio-respiratory fitness in ob
โœ Melania Manco; Valerio Nobili ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 42 KB ๐Ÿ‘ 1 views

Serum or plasma samples? The "Cinderella" role of blood collection procedures: Preanayltical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler Thr

Portal fibrosis and hepatic steatosis in
โœ Gary A. Abrams; Sachin S. Kunde; Audrey J. Lazenby; Ronald H. Clements ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB ๐Ÿ‘ 2 views

Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) that can lead to hepatic fibrosis and cirrhosis. Portal fibrosis in the absence of NASH, called isolated portal fibrosis (IPF), has received less attention and has not been classified as a spectrum

IฮบB kinase ฮต: A potential therapeutic ta
โœ James E. Nelson; Kris V. Kowdley ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB ๐Ÿ‘ 1 views

Obesity is associated with chronic low-grade inflammation that negatively impacts insulin sensitivity. Here, we show that high-fat diet can increase NF-B activation in mice, which leads to a sustained elevation in level of IB kinase โ‘€ (IKKโ‘€) in liver, adipocytes, and adipose tissue macrophages. IKKโ‘€